Court Strikes Down Agilent’s CRISPR Patents in Major IP Ruling
The dispute centers around Agilent’s U.S. Patents No. 10,337,001 and 10,900,034, which cover specific chemical modifications to CRISPR guide RNAs, particularly the incorporation of 2'-O-methyl (2'OMe) modifications. T...